An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation

• Published in: European journal of nuclear medicine and molecular imaging 2021-10, Vol.48 (11), p.3656-3665
• Main Authors: Miao, Wenjie, Nie, Pei, Yang, Guangjie, Wang, Yangyang, Yan, Lei, Zhao, Yujun, Yu, Ting, Yu, Mingming, Wu, Fengyu, Rao, Wei, Wang, Zhenguang
• Format: Article
• Language: English
• Subjects: Cardiology; Criteria; Decision analysis; Hepatocellular carcinoma; Imaging; Laboratories; Liver; Liver cancer; Liver transplantation; Liver transplants; Mathematical models; Medicine; Medicine & Public Health; Metabolism; Nomograms; Nuclear Medicine; Oncology; Oncology – Digestive tract; Original Article; Orthopedics; Parameters; Pathology; Patients; Performance evaluation; Positron emission tomography; Radiology; Reclassification; Statistical methods; Time dependence; Transplantation
• ISSN: 1619-7070; 1619-7089
• DOI: 10.1007/s00259-021-05328-w

Purpose To construct an FDG PET/CT metabolic parameter-based model to predict early recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT). Methods A total of 62 patients with HCC after LT were enrolled with a follow-up period of 1 year. Basic clinical, pathology, and laboratory data, CT features (CPLC), and PET metabolic parameters (CPLCP) were collected for model construction. A CPLC nomogram without metabolic parameters and a CPLCP nomogram with metabolic parameters were established. The net reclassification index (NRI) and integrated discrimination improvement (IDI) of the two models were calculated. The constructed model was compared with Milan criteria and University of California San Francisco (UCSF) criteria. The time-dependent area under the receiver operating characteristic curve (time-AUC) was used to compare the efficiency of the models, and the bootstrap method was used to for verification. Harrell’s concordance index (C-index) was used to evaluate the performance of these models. Decision curve analysis (DCA) was used to evaluate the clinical practicability of each model. Results Thirty out of 62 patients experienced a recurrence during the 1-year follow-up. BCLC stage ( P  = 0.009), MVI ( P  = 0.032), AFP ( P  = 0.004), CTdmax ( P  = 0.033), and MTV ( P  = 0.039) were the independent predictors. The CPLC nomogram and the CPLCP nomogram were established. Compared with the CPLC nomogram, the NRI of the CPLCP nomogram increased by 38.98% (95% CI = −18.77–60.43%) and the IDI increased by 4.40% (95% CI = −1.00–16.62%). The AUC value of the CPLCP nomogram was higher than those of Milan criteria and UCSF criteria in the time-AUC curve. Moreover, the CPLCP nomogram had a higher C-index (0.774) than other models. Finally, the DCA curve showed that clinical practicability of the CPLCP nomogram outperformed the Milan criteria and UCSF criteria. Conclusions The CPLCP nomogram combining basic clinical data, pathology data, laboratory data, CT features, and PET metabolic parameters showed good efficacy and high clinical practicability in predicting the early recurrence of HCC after LT.